title: Structure based design, synthesis, and evaluation of potential inhibitors of steroid sulfatase.
abstract: The activity of the enzyme steroid sulfatase (STS) is high in breast tumors and elevated levels of STS mRNA expression have been associated with a poor prognosis. Potent STS irreversible inhibitors have been developed, paving the way to use this new type of therapy for the treatment of breast cancer. Several small molecules belonging to a natural products-inspired library of previously obtained inhibitors of tumor cell growth and new molecules planned to be reversible inhibitors of this enzyme were docked into STS. Some of the synthesized xanthone derivatives, which revealed high scores against STS, namely oxo-9H-xanthene-3,6-diyl bis(3-chlorobenzoate) (5), 9-oxo-9H-xanthene-3,6-diyl bis(4-tertbutylbenzoate) (6) and 9-oxo-9H-xanthene-3,6-diyl bis(4-methoxybenzoate) (7) showed poor water solubility. Therefore, formulations of these derivatives with cyclodextrins were prepared and characterized. The compounds were evaluated regarding their effect on the in vitro growth of various human tumor cell lines, as well as the effect in STS inhibition, for the compounds with the most favorable ΔG values. Additionally, the capacity of these derivatives and of some prenyl and acetoxy-benzophenone and xanthones to inhibit the in vitro growth of MCF-7 ER(+) and/or to inhibit STS in a micromolar range was also assessed. Some compounds developed in the present work were shown to be potential STS inhibitors.
authors.forename: E V
authors.initials: EV
authors.lastname: Costa
authors.forename: E
authors.initials: E
authors.lastname: Sousa
authors.forename: K
authors.initials: K
authors.lastname: Choosang
authors.forename: S
authors.initials: S
authors.lastname: Singh
authors.forename: J
authors.initials: J
authors.lastname: Rocha
authors.forename: R T
authors.initials: RT
authors.lastname: Lima
authors.forename: P
authors.initials: P
authors.lastname: Pakkong
authors.forename: S
authors.initials: S
authors.lastname: Ahmed
authors.forename: M H
authors.initials: MH
authors.lastname: Vasconcelos
authors.forename: C A
authors.initials: CA
authors.lastname: Montanari
authors.affiliation: Centro de Quimica Medicinal - Universidade do Porto (CEQUIMED-UP), Porto, Portugal. esousa@ff.up.pt.
authors.forename: M M
authors.initials: MM
authors.lastname: Pinto
mesh_terms: D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000494:pharmacology*; D045744:Cell Line, Tumor; D004791:Enzyme Inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology*; D006801:Humans; D015394:Molecular Structure; D043266:Steryl-Sulfatase / Q000037:antagonists & inhibitors*; D013329:Structure-Activity Relationship
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D043266:Steryl-Sulfatase